Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

This publication has 14 references indexed in Scilit:

• Decreased Catabolism of Fluorouracil in Peripheral Blood Mononuclear Cells During Combination Therapy With Fluorouracil, Leucovorin, and Interferon -2a
  JNCI Journal of the National Cancer Institute, 1992
• Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study
  Cancer Chemotherapy and Pharmacology, 1992
• Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1990
• Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen
  Annals of Oncology, 1990
• Interferon effects upon fluorouracil metabolism by HL-60 cells
  Biochemical and Biophysical Research Communications, 1989
• Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study.
  Journal of Clinical Oncology, 1989
• 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer
  British Journal of Cancer, 1989
• [74] Quantitation of neutralization of interferon by antibody
  Published by Elsevier ,1986
• Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion
  British Journal of Cancer, 1978
• Chemotherapy of Gastrointestinal Cancer
  New England Journal of Medicine, 1978